{"schema_version":"secwatch.filing_event.v1","accession":"0000037785-23-000184","form_type":"8-K","ticker":"FMC","cik":"0000037785","company_name":"FMC CORP","filed_at":"2023-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.674876+00:00","generated_at":"2026-06-08T00:33:01.719822+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"FMC unveils strategic plan: 2024 rev $4.65-$4.85B, 2026 rev $5.5-$6.0B, asset review","bullets":["Preliminary 2024 outlook: revenue $4.65B-$4.85B, adj EBITDA $1.025B-$1.125B, FCF conversion >100%.","2026 goals: revenue $5.5B-$6.0B, adj EBITDA $1.3B-$1.5B.","Strategic review of non-core assets, including potential sale of Global Specialty Solutions (non-crop line).","2033 revenue aspiration: ~$2B from Plant Health, ~$2B from four new active ingredients in R&D pipeline.","New net leverage target of ~2x adjusted EBITDA over next 18-24 months."],"urls":{"canonical":"https://secwatch.observer/filing/0000037785-23-000184","json":"https://secwatch.observer/filing/0000037785-23-000184.json","markdown":"https://secwatch.observer/filing/0000037785-23-000184.md","text":"https://secwatch.observer/filing/0000037785-23-000184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/37785/000003778523000184/0000037785-23-000184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/37785/000003778523000184/fmc-20231117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:33:01.719822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}